Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
2009-01-21
Background: Rosiglitazone and pioglitazone may increase the incidence of fractures. We aimed to determine systematically the risk of fractures associated with thiazolidinedione therapy and to evaluate the effect of the therapy on bone density.